Filter
611
Filtered Results: 611
Text search:
molecular
markers
Featured
Recommendations
76
New Publications
124
Language
Document type
No document type
272
Guidelines
125
Studies & Reports
124
Manuals
43
Strategic & Response Plan
23
Training Material
10
Fact sheets
10
Situation Updates
3
Resource Platforms
1
Countries / Regions
India
51
Global
26
Kenya
15
Latin America and the Carribbean
15
Tanzania
14
Western and Central Europe
12
Africa
11
Ethiopia
10
South Africa
9
Nigeria
8
Eastern Europe
8
South–East Asia Region
6
Sierra Leone
5
Zimbabwe
5
Philippines
5
Uganda
5
Ukraine
4
Malawi
4
Asia
4
West and Central Africa
4
Western Pacific Region
4
East and Southern Africa
4
Indonesia
4
Nepal
3
Cameroon
3
Congo, Democratic Republic of
3
Brazil
3
Myanmar / Burma
3
Pakistan
3
Ghana
2
Benin
2
Syria
2
Burkina Faso
2
Guinea
2
USA
2
Venezuela
2
North America
2
Bangladesh
2
Zambia
2
Liberia
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Lesotho
1
China
1
Rwanda
1
Senegal
1
Afghanistan
1
Peru
1
Malaysia
1
Cambodia
1
Jordan
1
Germany
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Gabon
1
Japan
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Namibia
1
Georgia
1
Angola
1
Chad
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
169
Clinical Guidelines
101
Public Health
41
Pharmacy & Technologies
26
Key Resources
17
Women & Child Health
15
Capacity Building
4
Toolboxes
TB
79
AMR
63
COVID-19
60
HIV
39
NTDs
34
Rapid Response
32
Mental Health
30
Planetary Health
23
NCDs
17
Ebola & Marburg
14
Pharmacy
13
Refugee
8
Specific Hazards
6
Global Health Education
6
Zika
5
Polio
5
Conflict
4
Disability
3
Cholera
3
Caregiver
3
Natural Hazards
2
Health Financing Toolbox
2
Social Ethics
1
PLoS Negl Trop Dis 18(7): e0012282.
This review highlights common diagnostic
approaches for detecting schistosomiasis in field and clinical settings, major challenges,
and provides new and novel opportunities and diagnosis pathways that will be critical in sup-
porting elimination of schistosomi...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
Asthma is the most common chronic disease in children, imposing a consistent burden on health system. In recent years, prevalence of asthma symptoms became globally increased in children and adolescents, particularly in Low-Middle Income Countries (LMICs). Host (genetics, atopy) and environmental fa...
The WHO Cholera Rapid Diagnostic Test (RDT) Target Product Profile outlines the key requirements for developing improved cholera RDTs. It highlights the need for fast, accurate, and easy-to-use tests for early outbreak detection in resource-limited settings. The document sets desired and acceptable ...
Review
S Afr Med J 2014;104(3):174-177. DOI: 10.7196/SAMJ.7968
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
The Lancet Regional Health - Americas 2024;36: 100821 https://doi.org/10.1016/j.lana.2024.100821
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
A Summary
Accessed: 23.11.2019
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
Review Article:
The American Journal of the Medical Sciences 2011;341(6):493–498.]
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
J Infect Dis. (2012) 206 (suppl. 1): S61-S67
Influenza data gaps in sub-Saharan Africa include incidence, case fatality, seasonal patterns, and associations with prevalent disorders. The authors found that the burden of influenza was small during 2007–2010 in this paediatric hospital in Kenya. In...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
